ArticleFrontiers in surgery2022

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study.

Deguo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.